Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Renal Biomarker with Potential Clinical Applications in Monoclonal Gammopathy of Renal Significance (MGRS)

Eftathios Kastritis, Ioannis Papassotiriou, PhD, Maria Roussou, MD, Maria Gavriatopoulou, MD, Mantzou Aimilia, PhD, Erasmia Psimenou, MD, Smaragdi Marinaki, Charikleia Gakiopoulou, MD, Alexandra Margeli, PhD, Nikolaos Kanellias, MD, Magdalini Migkou, MD, Despina Fotiou, BMBS, MA, Ioannis Ntanasis-Stathopoulos, MD, Gerasimos-Petros Papassotiriou, PhD, Aristea-Maria Papanota, MD, Evangelos Terpos, MD PhD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 3126.

https://doi.org/10.1182/blood-2019-125305

Published: 2019

Journal Articles

Prevalence of Chronic Kidney Disease (CKD) in Lymphoma Survivors

Ghassan Al-Shbool, MD, Sameer Desale, MS, Judith Veis, MD, Vera Malkovska, MD, Sanjal Desai, MD

Blood (2019) 134 (Supplement_1): 2912.

https://doi.org/10.1182/blood-2019-129558

Published: 2019

Journal Articles

Risk Factors for Kidney Disease in Hb SC and Hb Sβ + -Thalassemia Sickle Cell Disease

Mandella Mensah, Binal N. Shah, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Mark T Gladwin, MD, Victor R Gordeuk, MD, Santosh L. Saraf, MD

Blood (2019) 134 (Supplement_1): 2299.

https://doi.org/10.1182/blood-2019-128668

Published: 2019

Journal Articles

Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group

Blood (2019) 134 (Supplement_1): 1840.

https://doi.org/10.1182/blood-2019-125235

Published: 2019

Journal Articles

Serum Neutrophil Gelatinase-Associated Lipocalin Independently Predicts for Renal Response in Myeloma Patients with Severe Renal Impairment

Meletios A. Dimopoulos, MD, Maria Roussou, MD, Eftathios Kastritis, Alexandra Margeli, PhD, Evangelos Eleutherakis-Papaiakovou, MD, Ioannis Ntanasis-Stathopoulos, MD, Nikolaos Kanellias, MD, Gerasimos-Petros Papassotiriou, PhD, Despina Fotiou, MD, Magdalini Migkou, MD, Maria Gavriatopoulou, MD, Erasmia Psimenou, MD, Ioannis Papassotiriou, PhD, Evangelos Terpos, MD PhD

Blood (2019) 134 (Supplement_1): 1877.

https://doi.org/10.1182/blood-2019-123912

Published: 2019

Journal Articles

Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)

Nosha Farhadfar, MD, Ajoy L. Dias, MD, Tao Wang, PhD, Caitrin Fretham, Hemant S. Murthy, MD, Brent R. Logan, Shin Mineishi, MD, Bipin N. Savani, MD, Edward A. Stadtmauer, MD FACP, Saurabh Chhabra, MD, John R. Wingard, MD, Siddhartha Ganguly, MD, Marcelo C. Pasquini, MDMS

Blood (2019) 134 (Supplement_1): 3256.

https://doi.org/10.1182/blood-2019-125761

Published: 2019

Journal Articles

Chronic Kidney Disease (CKD) in the U.S. Hemophilia Population: A Cohort Study

Blood (2018) 132 (Supplement 1): 2479.

https://doi.org/10.1182/blood-2018-99-119637

Published: 2018

Journal Articles

Retrospective Analysis of Modified Hyper-CVAD Therapy Combined with Proteasome Inhibition for Patients with Multiple Myeloma and Renal Insufficiency or Renal Failure

Derek Galligan, MD, Rupa Narayan, MD, Sarah Kim, PharmD, Ann Lazar, PhD MS, Marisela Tan, PharmD, Richard Fong, PharmD, Mimi Lo, PharmD, Nina Shah, MD, Shagun Arora, MD, Sandy W. Wong, MD, Thomas G. Martin, III, MD, Jeffrey Lee Wolf, MD

Blood (2018) 132 (Supplement 1): 3236.

https://doi.org/10.1182/blood-2018-99-111625

Published: 2018

Journal Articles

Orosomucoid As a Biomarker for Chronic Kidney Disease Associated with Sickle Cell Anemia

Ammanuel Taye, Nathan Smith, Nowah Kokou Apeadoufia Afangbedji, Xiaomei Niu, MD, James G. Taylor, MD, Marina Jerebtsova, PhD, Sergei Nekhai, PhD

Blood (2018) 132 (Supplement 1): 2352.

https://doi.org/10.1182/blood-2018-99-119477

Published: 2018

Journal Articles

Study of Metabolic Acidosis in Sickle Cell Disease Patients

Maud Cazenave, MD, Vincent Audard, MDPhD, Jean-Philippe Bertocchio, MDPhD, Anoosha Habibi, Caroline Bertoye, MD, Thomas Stehle, MD, Jugurtha Berkenou, Frédéric Galactéros, MD PhD, Pascal Houillier, Pablo Bartolucci, MD PhD, Marie Courbebaisse, MD PhD

Blood (2018) 132 (Supplement 1): 3667.

https://doi.org/10.1182/blood-2018-99-110235

Published: 2018

Journal Articles

Autologous Haematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma Complicated By Dialysis-Dependent Renal Failure

Maiia V. Firsova, MD PhD, Larisa P. Mendeleeva, MD PhD Prof, Irina G. Rekhtina, MD PhD, Maxim V. Solovev, MD, Olga S. Pokrovskaya, MD PhD, Eduard Gemdzhian, Ludmila S. Biryukova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 5765.

https://doi.org/10.1182/blood-2018-99-115880

Published: 2018

Journal Articles

Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function

Yevgeniya Foster, MD, Michael J Grant, MD, Samantha M Thomas, MS, Blake Cameron, MD MBI, Doug Raiff, PharmD, BCPS, Kelly Corbet, B.S., Christopher Ferreri, MD, Mitchell E. Horwitz, MD

Blood (2018) 132 (Supplement 1): 4594.

https://doi.org/10.1182/blood-2018-99-113189

Published: 2018

Journal Articles

Vulnerability Variables Among Octogenarians Myeloma Patients: A Single-Center Analysis in 110 Patients

Maria Gavriatopoulou, Despina Fotiou, Maria Roussou, Magdalini Migkou, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Dimitrios C. Ziogas, Ioannis Panagiotidis, Dimitra Gika, Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, MD PhD, Eftathios Kastritis, Meletios A. Dimopoulos

Blood (2017) 130 (Supplement 1): 3152.

https://doi.org/10.1182/blood.V130.Suppl_1.3152.3152

Published: 2017

Journal Articles

Renal Response in Relapsed Refractory Multiple Myeloma Patients with Severe Renal Impairment at treatment Initiation: Intermediate Data of a Large, Observational, Prospective Study

Blood (2017) 130 (Supplement 1): 1878.

https://doi.org/10.1182/blood.V130.Suppl_1.1878.1878

Published: 2017

Journal Articles

Shingles Occurs in Only 0.5% of Myeloma Patients on Any Dose of Antiviral Prophylaxis

Jacqueline Chu, BA, Syed Basir Hussaini, BS, Nidhi Sharma, PhD, Nita Williams, BS, Don M Benson, Jr., MD PhD, Ashley E Rosko, MD, Yvonne A Efebera, MD, Craig C Hofmeister, MDMPH

Blood (2017) 130 (Supplement 1): 4645.

https://doi.org/10.1182/blood.V130.Suppl_1.4645.4645

Published: 2017

Journal Articles

Chronic Kidney Disease in the U.S. Hemophilia Population: A Cohort Study

Blood (2017) 130 (Supplement 1): 2359.

https://doi.org/10.1182/blood.V130.Suppl_1.2359.2359

Published: 2017

Journal Articles

Prognostic Comparison Between ISS and R-ISS in Real-Life Setting of Myeloma Patients: An Example of Utilization of Electronic Biobank Database

Samu Kurki, PhD, Klaus Tamminen, MD, Tatu Miettinen, MD, Kari Remes, MD PhD

Blood (2016) 128 (22): 5645.

https://doi.org/10.1182/blood.V128.22.5645.5645

Published: 2016

Journal Articles

Circulating Adiponectin and Markers of Endothelial and Cardiovascular Dysfunction Correlate with Disease Burden in Newly Diagnosed Patients with Multiple Myeloma; Increase of Adiponectin after Bortezomib- and IMiD-Based Regimens

Evangelos Terpos, Ioannis Papassotiriou, Efstathios Kastritis, MD, Gerasimos-Petros Papassotiriou, Dimitrios Christoulas, Nikolaos Kanellias, Anna Komitopoulou, Evangelos Eleutherakis-Papaiakovou, Ioannis Panagiotidis, Maria Gavriatopoulou, Emilia Mantzou, Meletios A. Dimopoulos

Blood (2016) 128 (22): 4446.

https://doi.org/10.1182/blood.V128.22.4446.4446

Published: 2016

Journal Articles

Factors Related to the Progression of Sickle Cell Disease Nephropathy

Julia Z. Xu, MD, Melanie E. Garrett, MS, Karen L. Soldano, BS, Sean T. Chen, Allison E. Ashley-Koch, PhD, Marilyn J. Telen, MD

Blood (2016) 128 (22): 9.

https://doi.org/10.1182/blood.V128.22.9.9

Published: 2016

Journal Articles

Iron Overload of the Kidneys of Patients with Thalassemia and Sickle-Cell Disease: Final Results of a Prospective Study in 224 Patients Using Magnetic Resonance Imaging T2 and R2* Techniques

Ersi Voskaridou, Dimitrios Christoulas, Maria Dimopoulou, Konstantina Repa, Maroussa Douskou, Evangelos Terpos

Blood (2015) 126 (23): 2157.

https://doi.org/10.1182/blood.V126.23.2157.2157

Published: 2015

NARROW

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Is a Renal Biomarker with Potential Clinical Applications in Monoclonal Gammopathy of Renal Significance (MGRS)

Prevalence of Chronic Kidney Disease (CKD) in Lymphoma Survivors

Risk Factors for Kidney Disease in Hb SC and Hb Sβ + -Thalassemia Sickle Cell Disease

Patterns of Renal Recovery and Toxicity with Novel Agent-Based Induction Triplets in Newly Diagnosed Multiple Myeloma - an Analysis of Two Prospective Studies By the German DSMM Myeloma Study Group

Serum Neutrophil Gelatinase-Associated Lipocalin Independently Predicts for Renal Response in Myeloma Patients with Severe Renal Impairment

Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)

Chronic Kidney Disease (CKD) in the U.S. Hemophilia Population: A Cohort Study

Retrospective Analysis of Modified Hyper-CVAD Therapy Combined with Proteasome Inhibition for Patients with Multiple Myeloma and Renal Insufficiency or Renal Failure

Orosomucoid As a Biomarker for Chronic Kidney Disease Associated with Sickle Cell Anemia

Study of Metabolic Acidosis in Sickle Cell Disease Patients

Autologous Haematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma Complicated By Dialysis-Dependent Renal Failure

Treatment with Foscarnet after Allogeneic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function

Vulnerability Variables Among Octogenarians Myeloma Patients: A Single-Center Analysis in 110 Patients

Renal Response in Relapsed Refractory Multiple Myeloma Patients with Severe Renal Impairment at treatment Initiation: Intermediate Data of a Large, Observational, Prospective Study

Shingles Occurs in Only 0.5% of Myeloma Patients on Any Dose of Antiviral Prophylaxis

Chronic Kidney Disease in the U.S. Hemophilia Population: A Cohort Study

Prognostic Comparison Between ISS and R-ISS in Real-Life Setting of Myeloma Patients: An Example of Utilization of Electronic Biobank Database

Circulating Adiponectin and Markers of Endothelial and Cardiovascular Dysfunction Correlate with Disease Burden in Newly Diagnosed Patients with Multiple Myeloma; Increase of Adiponectin after Bortezomib- and IMiD-Based Regimens

Factors Related to the Progression of Sickle Cell Disease Nephropathy

Iron Overload of the Kidneys of Patients with Thalassemia and Sickle-Cell Disease: Final Results of a Prospective Study in 224 Patients Using Magnetic Resonance Imaging T2 and R2* Techniques

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only